Mathematical modelling of the impact of vaccination, treatment and media awareness on the hepatitis B epidemic in Burkina Faso
Abstract
Infection with the hepatitis B virus (HBV) remains a global public health issue. Particularly in Burkina Faso, HBV is a major public health concern due to its high prevalence and associated mortality. However, universal vaccination, treatment of chronic carriers, and awareness campaigns are currently employed means in Burkina Faso to combat the spread of HBV. Therefore, this paper aims to study the impact of these control measures on the expansion of this virus. This paper presents a mathematical model of vertically transmitted HBV that takes into account the progression to chronicity as a function of the age of the infected person, as well as vaccination, treatment of chronic carriers, and media awareness. After formulating the model and carrying out the mathematical analysis, we simulated the proposed model in Matlab, taking into account the various involved parameters. Finally, we presented the results of sensitivity analysis and numerical simulation. According to our model, with vaccination coverage of $30\%$, a $50\%$ success rate of awareness campaigns and $20\%$ effectiveness for the $10\%$ of treated chronic carriers, the prevalence of hepatitis B infection could decrease down to $2\%$ within thirty years in Burkina Faso.
Keywords
Hepatitis B, effective reproduction number, sensitivity analysis, vaccination
Supporting Institution
No financial support
Thanks
The authors are grateful to the editor and the journal for the opportunity to showcase their work through this prestigious journal. Many thanks.
References
- [1] World Health Organization, Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016-2021. World Health Organization, (2019).
- [2] Ministère de la Santé. Normes et Protocoles de Prise en Charge des Hépatites Virales au Burkina Faso, (2019). Ministère de la santé du Burkina Faso, https://scge-cm.com/download.
- [3] Masseta, M. Incidental discovery of HBs antigen at the Y.O. University Hospital: socio-demographic, clinical and paraclinical aspects, PhD Thesis, Joseph Ki-Zerbo University, (2018).
- [4] Banach, M. (2022). Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. GBD 2019 Hepatitis B Collaborator. The Lancet Gastroenterology and Hepatology, 7(9), 796 -829, (2022).
- [5] Ott, J.J., Stevens, G.A., Groeger, J. and Wiersma, S.T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 30(12), 2212-2219, (2012).
- [6] Ministry of Health, Burkina. Hepatitis B, cirrhosis and primary liver cancer kill nearly 5,000 people a year by Editorial Board, Ouagadougou, Fasozine, (2017). https://fasozine.com.
- [7] Meda, N., Tuaillon, E., Kania, D., Tiendrebeogo, A., Pisoni, A., Zida, S., ... and Dujols, P. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study. Bulletin of the World Health Organization, 96(11), 750, (2018).
- [8] Zouré, A.A., Nadembega, C., Ouattara, A.K., Traoré, L., Tiemtoré, A., Sawadogo, O., ... and Simpore, J. State of the HIV, Hepatitis B and C Virus Pandemic from 2003 to 2022 in Burkina Faso: Evolution of Prevalence Trends and Strategic Recommendations to Achieve the WHO’s Goal for Their Eradication by 2030. Advances in Infectious Diseases Scientific Research Publishing, 14(3) 628–643 (2024).
- [9] Tao, I., Compaoré, T.R., Diarra, B., Djigma, F., Zohoncon, T.M., Assih, M., ... and Simpore, J. Seroepidemiology of hepatitis B and C viruses in the general population of Burkina Faso. Hepatitis Research and Treatment, 2014(1), 781843, (2014).
- [10] Guingané, A.N., Kaboré, R., Shimakawa, Y., Somé, E.N., Kania, D., Pisoni, A., ... and Tuaillon, E. Screening for Hepatitis B in partners and children of women positive for surface antigen, Burkina Faso. Bulletin of the World Health Organization, 100(4), 256, (2022).